Literature DB >> 8225869

Transplantation of Y79 cells into rat eyes: an in vivo model of human retinoblastomas.

M del Cerro1, G M Seigel, E Lazar, D Grover, C del Cerro, D H Brooks, D DiLoreto, G Chader.   

Abstract

PURPOSE: To develop an in vivo model of human retinoblastoma by returning cultured Y79 retinoblastoma cells to the retinal environment of a widely available laboratory animal. In so doing, to study the survival, integration, and invasive characteristics expressed by tumoral cells grafted into an intraocular milieu from which these progenitor cells originated more than 20 years ago.
METHODS: Using the retinal grafting method of Lazar and del Cerro, Y79 cells were injected under direct visualization into the subretinal space of Fischer 344 rats. The host rats included 36 animals that received daily injections of cyclosporin A and 4 that did not. All hosts were sacrificed 30 to 60 days after transplantation.
RESULTS: Clinical examination showed vitreal invasion by masses of flocculent white material or the intravitreal formation of solid tumors. Histologic examination showed these formations to be outgrowths of grafted tumoral cells into the host retina and vitreal cavity. Highly anaplastic tumoral cells were also found lodged in subretinal and intraretinal locations. There were signs of continued and intense cell division within the grafts, with no indication of cell-mediated host reaction against the grafted cells.
CONCLUSIONS: After intraretinal xenografting, human Y79 retinoblastoma cells retain a highly tumoral nature despite many years of in vitro propagation. When xenografted, these cells survive, grow, and express their malignancy within the retina of the common laboratory rat protected by a moderate immunosuppressive regimen. This partial immunosuppression is a requirement for the xenografts to prosper. This model offers a valuable opportunity to study in vivo the cellular and molecular biology of this and other human retinoblastomas, and it may facilitate the evaluation of antitumoral treatments.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225869

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Metastatic and nonmetastatic models of retinoblastoma.

Authors:  P Chévez-Barrios; M Y Hurwitz; K Louie; K T Marcus; V N Holcombe; P Schafer; C E Aguilar-Cordova; R L Hurwitz
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Tumor-associated retinal astrocytes promote retinoblastoma cell proliferation through production of IGFBP-5.

Authors:  Xiaoliang L Xu; Thomas C Lee; Nneka Offor; Christine Cheng; Aihong Liu; Yuqiang Fang; Suresh C Jhanwar; David H Abramson; David Cobrinik
Journal:  Am J Pathol       Date:  2010-05-27       Impact factor: 4.307

3.  Recoverin expression in the R28 retinal precursor cell line.

Authors:  G M Seigel; A L Mutchler; G Adamus; E L Imperato-Kalmar
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.416

4.  Re-characterization of established human retinoblastoma cell lines.

Authors:  Maike Busch; Claudia Philippeit; Andreas Weise; Nicole Dünker
Journal:  Histochem Cell Biol       Date:  2014-10-19       Impact factor: 4.304

5.  Giant Y79 retinoblastoma cells contain functionally active T-type calcium channels.

Authors:  Sooyun Kim; Segundo Jose Guzman; Dong Hyun Jo; Chang Sik Cho; Jeong Hun Kim
Journal:  Pflugers Arch       Date:  2021-08-15       Impact factor: 4.458

Review 6.  A comprehensive review of intravitreal immunosuppressants and biologicals used in ophthalmology.

Authors:  Nasiq Hasan; Rohan Chawla; Nawazish Shaikh; Sindhuja Kandasamy; Shorya Vardhan Azad; M Dheepak Sundar
Journal:  Ther Adv Ophthalmol       Date:  2022-05-18

7.  Animal models in retinoblastoma research.

Authors:  Rohini M Nair; Swathi Kaliki; Geeta K Vemuganti
Journal:  Saudi J Ophthalmol       Date:  2013-07

Review 8.  Heterogeneity in retinoblastoma: a tale of molecules and models.

Authors:  Sonya Stenfelt; Maria K E Blixt; Charlotta All-Ericsson; Finn Hallböök; Henrik Boije
Journal:  Clin Transl Med       Date:  2017-11-09

9.  Establishment of a novel retinoblastoma (Rb) nude mouse model by intravitreal injection of human Rb Y79 cells - comparison of in vivo analysis versus histological follow up.

Authors:  Alexander V Tschulakow; Ulrich Schraermeyer; H Peter Rodemann; Sylvie Julien-Schraermeyer
Journal:  Biol Open       Date:  2016-11-15       Impact factor: 2.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.